Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03825224 · ClinicalTrials.gov registry record
Evaluation of MyoStrain™ in Clinical Practice
A clinical trial of Coronary Artery Disease and Amyloidosis, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 19
- Enrollment target
- 1
- Study location
NCT03825224 is a study of Coronary Artery Disease and Amyloidosis that has completed, run by University of Kansas Medical Center. The registered enrollment target is 19 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03825224, a study of Coronary Artery Disease and Amyloidosis, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice
Conditions Studied
Interventions
- PROCEDURE Diagnostic Test: Myostrain
Study Locations (1)
Kansas
- The University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2019-11-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03825224
The ClinicalTrials.gov registry entry for NCT03825224 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Diagnostic Test: Myostrain is the first listed.
NCT03825224 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT03825224 about?
NCT03825224 is a clinical study titled "Evaluation of MyoStrain™ in Clinical Practice". Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice
What is the current status of trial NCT03825224?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2019-04-15. Estimated completion is 2019-11-15.
What conditions does trial NCT03825224 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Amyloidosis, Sarcoidosis, Lupus, Myocarditis.
What interventions are being tested in trial NCT03825224?
The interventions under investigation include: Diagnostic Test: Myostrain (PROCEDURE).
Who is sponsoring clinical trial NCT03825224?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03825224 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.